| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7169401 | HILL DERMACEUTICALS | Topical skin care composition containing refined peanut oil |
Jul, 2023
(2 months ago) | |
Tolak is owned by Hill Dermaceuticals.
Tolak contains Fluorouracil.
Tolak has a total of 1 drug patent out of which 1 drug patent has expired.
Expired drug patents of Tolak are:
- US7169401
Tolak was authorised for market use on 18 September, 2015.
Tolak is available in cream;topical dosage forms.
The generics of Tolak are possible to be released after 18 July, 2023.
Drugs and Companies using FLUOROURACIL ingredient
Market Authorisation Date: 18 September, 2015
Treatment: NA
Dosage: CREAM;TOPICAL
More Information on Dosage
TOLAK family patents
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic